BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld
BioWorld
April 3, 2002
View Archived Issues
Kalypsys Raises $43M In First Round, Plans Platform Growth
Kalypsys Inc. raised $43 million in its first round of financing and will now look to grow the technology that gave it its start. (BioWorld Today)
Read More
Microbia Gets $26M In Series C To Fund Anti-Infective Drugs
Read More
Maternal Autoantibodies Confer Type I Diabetes On Transgenic, Disease-Modeling NOD Embryo
Read More
Ambit Enters Collaboration With AstraZeneca On Protein Targets
Read More
Other News To Note
Read More